How to Boost Your Immune System Against Corona-virus Infection?

How to boost your bottom line with an office procedure.

practices’ expenses continue to grow at a faster pace than revenues, physicians are under greater pressure to do more with less. While working harder and seeing increasing numbers of patients each day is an option, finding methods to work smarter is becoming an attractive alternative. One viable strategy for your practice is to increase charges per unit of time. Performing more procedures is a ...

How Hepatitis C Virus Infection Contributes to Cardiovascular Disease: A Systematic Review

How to Fragment Your File System

Yang Zhan is a PhD student at the University of North Carolina at Chapel Hill and is advised by Donald Porter. His research mainly focuses on writeoptimized data structures. He also works on concurrent data structures. [email protected] File systems attempt to avoid aging, or fragmentation over time, by strategically allocating space for files. System implementers and users alike treat aging as ...

Innate immune responses against Epstein Barr virus infection.

EBV persists life-long in >95% of the human adult population. Whereas it is perfectly immune-controlled in most infected individuals, a minority develops EBV-associated diseases, primarily malignancies of B cell and epithelial cell origin. In recent years, it has become apparent that the course of primary infection determines part of the risk to develop EBV-associated diseases. Particularly, th...

designing a novel chimeric antigen to stimulate the immune system against brucella infection

brucellosis is a well-known infectious disease among domestic animals caused by brucella bacterium. omp25 is an outer membrane protein of brucella which plays an important role in immunogenicity of cells. moreover, brucella lumazine synthase (bls) as another main antigen can be used as an adjuvant when covalently attached to a foreign antigen. in the current study, designing and production of a...

A boost for the immune system.

Protease inhibitor therapy dramatically reduces HIV viral load, however, when patients stop taking their medications, their viral load can rebound. A new product called remune (the Salk HIV vaccine) appears to enhance the immune system's response to HIV. However, since remune is a therapeutic vaccine, it cannot prevent HIV infection. Clinical trials of remune are expected to begin in Canada.